These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

458 related items for PubMed ID: 11948125

  • 1. Bombesin receptor subtypes in human cancers: detection with the universal radioligand (125)I-[D-TYR(6), beta-ALA(11), PHE(13), NLE(14)] bombesin(6-14).
    Reubi JC, Wenger S, Schmuckli-Maurer J, Schaer JC, Gugger M.
    Clin Cancer Res; 2002 Apr; 8(4):1139-46. PubMed ID: 11948125
    [Abstract] [Full Text] [Related]

  • 2. High expression of gastrin-releasing peptide receptors in the vascular bed of urinary tract cancers: promising candidates for vascular targeting applications.
    Fleischmann A, Waser B, Reubi JC.
    Endocr Relat Cancer; 2009 Jun; 16(2):623-33. PubMed ID: 19478282
    [Abstract] [Full Text] [Related]

  • 3. Gastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation.
    Markwalder R, Reubi JC.
    Cancer Res; 1999 Mar 01; 59(5):1152-9. PubMed ID: 10070977
    [Abstract] [Full Text] [Related]

  • 4. Androgen-dependent expression of the gastrin-releasing peptide receptor in human prostate tumor xenografts.
    de Visser M, van Weerden WM, de Ridder CM, Reneman S, Melis M, Krenning EP, de Jong M.
    J Nucl Med; 2007 Jan 01; 48(1):88-93. PubMed ID: 17204703
    [Abstract] [Full Text] [Related]

  • 5. Concomitant vascular GRP-receptor and VEGF-receptor expression in human tumors: molecular basis for dual targeting of tumoral vasculature.
    Reubi JC, Fleischmann A, Waser B, Rehmann R.
    Peptides; 2011 Jul 01; 32(7):1457-62. PubMed ID: 21605611
    [Abstract] [Full Text] [Related]

  • 6. Characterization of bombesin/gastrin-releasing peptide receptors in human breast cancer and their relationship to steroid receptor expression.
    Halmos G, Wittliff JL, Schally AV.
    Cancer Res; 1995 Jan 15; 55(2):280-7. PubMed ID: 7812958
    [Abstract] [Full Text] [Related]

  • 7. Effective inhibition of experimental human ovarian cancers with a targeted cytotoxic bombesin analogue AN-215.
    Engel JB, Keller G, Schally AV, Halmos G, Hammann B, Nagy A.
    Clin Cancer Res; 2005 Mar 15; 11(6):2408-15. PubMed ID: 15788692
    [Abstract] [Full Text] [Related]

  • 8. Discovery of potent and selective peptide agonists at the GRP-preferring bombesin receptor (BB2).
    Darker JG, Brough SJ, Heath J, Smart D.
    J Pept Sci; 2001 Nov 15; 7(11):598-605. PubMed ID: 11763364
    [Abstract] [Full Text] [Related]

  • 9. Peptide structural requirements for antagonism differ between the two mammalian bombesin receptor subtypes.
    Lin JT, Coy DH, Mantey SA, Jensen RT.
    J Pharmacol Exp Ther; 1995 Oct 15; 275(1):285-95. PubMed ID: 7562561
    [Abstract] [Full Text] [Related]

  • 10. Co-expressed peptide receptors in breast cancer as a molecular basis for in vivo multireceptor tumour targeting.
    Reubi C, Gugger M, Waser B.
    Eur J Nucl Med Mol Imaging; 2002 Jul 15; 29(7):855-62. PubMed ID: 12111125
    [Abstract] [Full Text] [Related]

  • 11. Discovery of a novel class of neuromedin B receptor antagonists, substituted somatostatin analogues.
    Orbuch M, Taylor JE, Coy DH, Mrozinski JE, Mantey SA, Battey JF, Moreau JP, Jensen RT.
    Mol Pharmacol; 1993 Oct 15; 44(4):841-50. PubMed ID: 7901752
    [Abstract] [Full Text] [Related]

  • 12. Preclinical comparison of (111)In-labeled DTPA- or DOTA-bombesin analogs for receptor-targeted scintigraphy and radionuclide therapy.
    Breeman WA, de Jong M, Erion JL, Bugaj JE, Srinivasan A, Bernard BF, Kwekkeboom DJ, Visser TJ, Krenning EP.
    J Nucl Med; 2002 Dec 15; 43(12):1650-6. PubMed ID: 12468515
    [Abstract] [Full Text] [Related]

  • 13. 177Lu-AMBA: Synthesis and characterization of a selective 177Lu-labeled GRP-R agonist for systemic radiotherapy of prostate cancer.
    Lantry LE, Cappelletti E, Maddalena ME, Fox JS, Feng W, Chen J, Thomas R, Eaton SM, Bogdan NJ, Arunachalam T, Reubi JC, Raju N, Metcalfe EC, Lattuada L, Linder KE, Swenson RE, Tweedle MF, Nunn AD.
    J Nucl Med; 2006 Jul 15; 47(7):1144-52. PubMed ID: 16818949
    [Abstract] [Full Text] [Related]

  • 14. Overexpression of gastrin-releasing peptide receptors in tumor-associated blood vessels of human ovarian neoplasms.
    Fleischmann A, Waser B, Reubi JC.
    Cell Oncol; 2007 Jul 15; 29(5):421-33. PubMed ID: 17726264
    [Abstract] [Full Text] [Related]

  • 15. Gastrin releasing peptide in human neuroendocrine tumours.
    Bostwick DG, Bensch KG.
    J Pathol; 1985 Dec 15; 147(4):237-44. PubMed ID: 3003308
    [Abstract] [Full Text] [Related]

  • 16. Cholecystokinin(CCK)-A and CCK-B/gastrin receptors in human tumors.
    Reubi JC, Schaer JC, Waser B.
    Cancer Res; 1997 Apr 01; 57(7):1377-86. PubMed ID: 9102227
    [Abstract] [Full Text] [Related]

  • 17. Expression of mRNA for gastrin-releasing peptide receptor by human bronchial epithelial cells. Association with prolonged tobacco exposure and responsiveness to bombesin-like peptides.
    Siegfried JM, DeMichele MA, Hunt JD, Davis AG, Vohra KP, Pilewski JM.
    Am J Respir Crit Care Med; 1997 Aug 01; 156(2 Pt 1):358-66. PubMed ID: 9279210
    [Abstract] [Full Text] [Related]

  • 18. Systematic optimization of a lead-structure identities for a selective short peptide agonist for the human orphan receptor BRS-3.
    Weber D, Berger C, Heinrich T, Eickelmann P, Antel J, Kessler H.
    J Pept Sci; 2002 Aug 01; 8(8):461-75. PubMed ID: 12212809
    [Abstract] [Full Text] [Related]

  • 19. Comparative pharmacology of the nonpeptide neuromedin B receptor antagonist PD 168368.
    Ryan RR, Katsuno T, Mantey SA, Pradhan TK, Weber HC, Coy DH, Battey JF, Jensen RT.
    J Pharmacol Exp Ther; 1999 Sep 01; 290(3):1202-11. PubMed ID: 10454496
    [Abstract] [Full Text] [Related]

  • 20. Gastrin-releasing peptide receptors in non-neoplastic and neoplastic human breast.
    Gugger M, Reubi JC.
    Am J Pathol; 1999 Dec 01; 155(6):2067-76. PubMed ID: 10595936
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.